BiondVax Pharmaceuticals Ltd. BVXV
Set alert
1.36 0.00 0.00%
As of Sep 6, 3:59 PM ET
1.31 Day range 1.36
52-week range unavailable
- Open
- 1.32
- Prev close
- 1.36
- Mkt cap
- 4.97M
- Vol
- 22.67K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.31
- High
- 1.36
- Forward P/E
- -0.59
- Beta
- 2.38
- Short ratio
- 0.03
- Inst. own
- 0.02%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 11, 2023
- 50-d avg
- 1.62
- 200-d avg
- 3.97
- 1y target
- 39.00
Analyst view
Price target (mean) 39.00 +2767.6% upside
Now 1.36
- Target (low)
- 8.00
- Target (mean)
- 39.00
- Target (high)
- 70.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.91 | -0.91 – -0.91 | -2.00 | +54.5% | 0 | 0.0% | 1 |
| Next quarter | -0.99 | -0.99 – -0.99 | -0.20 | -395.0% | 0 | 0.0% | 1 |
| Current year | -2.55 | -4.10 – -1.00 | 0.00 | 0.0% | 0 | 0.0% | 2 |
| Next year | 0.00 | 0.00 – 0.00 | -2.55 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 26, 2022 | Aegis Capital | Initiated | — | Buy |
| Jun 26, 2015 | Aegis Capital | Initiated | — | Buy |